ExL’s Clinical Data Disclosure Summit brings together industry executives to discuss various strategies for publicizing clinical data while exploring the positive and negative ramifications. Following a year of much media attention and increased requirements for data disclosure, the third event promises to be their best yet.
WilmerHale Partner Scott Lassman will speak on a panel entitled, "What is the purpose of the Data Disclosure Initiative? Are we achieving it?"